Causes, consequences, and treatment of osteoporosis in men

Jameela Banu

Research output: Contribution to journalReview articlepeer-review

26 Scopus citations


Men undergo gradual bone loss with aging, resulting in fragile bones. It is estimated that one in five men will suffer an osteoporotic fracture during their lifetime. The prognosis for men after a hip fracture is very grim. A major cause is reduction of free testosterone. Many other factors result in secondary osteoporosis, including treatment for other diseases such as cancer and diabetes. Patients should be screened not only for bone density but also assessed for their nutritional status, physical activity, and drug intake. Therapy should be chosen based on the type of osteoporosis. Available therapies include testosterone replacement, bisphosphonates, and nutritional supplementation with calcium, vitamin D, fatty acids, and isoflavones, as well as certain specific antibodies, like denosumab and odanacatib, and inhibitors of certain proteins.

Original languageEnglish (US)
Pages (from-to)849-860
Number of pages12
JournalDrug Design, Development and Therapy
StatePublished - Aug 21 2013


  • Antibodies
  • Bisphosphonates
  • Hormones
  • Male osteoporosis
  • Nutritional supplements
  • Protein inhibitors
  • Risk factors

ASJC Scopus subject areas

  • Pharmacology
  • Pharmaceutical Science
  • Drug Discovery


Dive into the research topics of 'Causes, consequences, and treatment of osteoporosis in men'. Together they form a unique fingerprint.

Cite this